Advertisement
Screener

Morphic Holding, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Morphic Holding, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 54 rows, 54 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2024-08-16: Reporting owner Tipirneni Praveen P.; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2024-08-16: Reporting owner Tipirneni Praveen P.; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2024-08-16: Reporting owner Tipirneni Praveen P.; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2024-08-16: Reporting owner Cooper Simon Peter; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2024-08-16Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−88,500
0 owned after
no price filed2024-08-20
2024-08-16Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−25,000
0 owned after
no price filed2024-08-20
2024-08-16Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−136,800
0 owned after
no price filed2024-08-20
2024-08-16Cooper Simon Peter
Officer (CMO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−14,000
0 owned after
no price filed2024-08-20
2024-08-16Cooper Simon Peter
Officer (CMO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−7,000
0 owned after
no price filed2024-08-20
2024-08-16DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−32,850
0 owned after
no price filed2024-08-20
2024-08-16DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−6,500
0 owned after
no price filed2024-08-20
2024-08-16DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−44,400
0 owned after
no price filed2024-08-20
2024-08-16Rogers Bruce
Officer (PRESIDENT)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−45,675
0 owned after
no price filed2024-08-20
2024-08-16Rogers Bruce
Officer (PRESIDENT)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−10,140
0 owned after
no price filed2024-08-20
2024-08-16Rogers Bruce
Officer (PRESIDENT)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−85,800
0 owned after
no price filed2024-08-20
2024-08-16SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−44,025
0 owned after
no price filed2024-08-20
2024-08-16SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−9,380
0 owned after
no price filed2024-08-20
2024-08-16SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−85,800
0 owned after
no price filed2024-08-20
2024-08-16Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−38,025
0 owned after
no price filed2024-08-20
2024-08-16Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−6,940
0 owned after
no price filed2024-08-20
2024-08-16Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−62,400
0 owned after
no price filed2024-08-20
2024-03-18Cooper Simon Peter
Officer (CMO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+14,000
14,000 owned after
$0.002024-03-19
2024-03-18Cooper Simon Peter
Officer (CMO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,000
7,000 owned after
$0.002024-03-19
2024-01-14Tipirneni Praveen P.
Director, Officer (CEO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−12,500
25,000 owned after
$0.002024-01-17
2024-01-14SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−4,690
9,380 owned after
$0.002024-01-17
2024-01-14Rogers Bruce
Officer (President)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−5,070
10,140 owned after
$0.002024-01-17
2024-01-14Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,470
6,940 owned after
$0.002024-01-17
2024-01-14DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,250
6,500 owned after
$0.002024-01-17
2024-01-13Tipirneni Praveen P.
Director, Officer (CEO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−29,500
88,500 owned after
$0.002024-01-17
2024-01-13SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−14,675
44,025 owned after
$0.002024-01-17
2024-01-13Rogers Bruce
Officer (President)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−15,225
45,675 owned after
$0.002024-01-17
2024-01-13Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−12,675
38,025 owned after
$0.002024-01-17
2024-01-13DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,950
32,850 owned after
$0.002024-01-17
2024-01-12Tipirneni Praveen P.
Director, Officer (CEO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+136,800
136,800 owned after
$0.002024-01-17
2024-01-12SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+85,800
85,800 owned after
$0.002024-01-17
2024-01-12Rogers Bruce
Officer (President)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+85,800
85,800 owned after
$0.002024-01-17
2024-01-12Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+62,400
62,400 owned after
$0.002024-01-17
2024-01-12DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+44,400
44,400 owned after
$0.002024-01-17
2023-01-14DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+3,250
9,750 owned after
$0.002023-01-18
2023-01-14Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+3,470
10,410 owned after
$0.002023-01-18
2023-01-14Rogers Bruce
Officer (President)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+5,070
15,210 owned after
$0.002023-01-18
2023-01-14SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+4,690
14,070 owned after
$0.002023-01-18
2023-01-14Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+12,500
37,500 owned after
$0.002023-01-18
2023-01-13DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+43,800
43,800 owned after
$0.002023-01-18
2023-01-13Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,700
50,700 owned after
$0.002023-01-18
2023-01-13Rogers Bruce
Officer (President)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+60,900
60,900 owned after
$0.002023-01-18
2023-01-13SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+58,700
58,700 owned after
$0.002023-01-18
2023-01-13Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+118,000
118,000 owned after
$0.002023-01-18
2022-01-14Tipirneni Praveen P.
Director, Officer (President and CEO)
4Restricted Stock Units (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$0.002022-01-19
2022-01-14SCHEGERIN MARC
Officer (CFO and COO)
4Restricted Stock Units (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,760
18,760 owned after
$0.002022-01-19
2022-01-14Rogers Bruce
Officer (Chief Scientific Officer)
4Restricted Stock Units (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+20,280
20,280 owned after
$0.002022-01-19
2022-01-14Farrell Robert E Jr
Officer (SVP Finance and CAO)
4Restricted Stock Units (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+13,880
13,880 owned after
$0.002022-01-19
2022-01-14DeVaul William
Officer (General Counsel and Secretary)
4Restricted Stock Units (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+13,000
13,000 owned after
$0.002022-01-19
2021-09-16Linde Peter
Officer (Chief Medical Officer)
4Restricted Stock Unit (RSU
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,378
0 owned after
$0.002021-09-17
2021-03-16Linde Peter
Officer (Chief Medical Officer)
4Restricted Stock Unit (RSU)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−11,365
34,095 owned after
$0.002021-03-17
2021-03-16Linde Peter
Officer (Chief Medical Officer)
4Restricted Stock Unit (RSU)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,378
10,378 owned after
$0.002021-03-17
2020-03-16Linde Peter
Officer (Chief Medical Officer)
4Restricted Stock Unit (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+45,460
45,460 owned after
$0.002020-03-18
2020-03-16Linde Peter
Officer (Chief Medical Officer)
4Restricted Stock Unit (RSU)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+20,756
20,756 owned after
$0.002020-03-18